ABclonal
Latest round
- Series D
Last raised
- Dec 2021
Total raised
- $373M
Investors
- 24
About ABclonal
Based in Wuhan, China, ABclonal, Inc. is a biotechnology company that provides medical products and contract research organization (CRO) services. In 2011, the company launched the human genome antibody library research and development plan. In 2017, the company introduced molecular enzymes and NGS library building kit products. In 2020, the company has developed raw materials for COVID-19 nucleic acid detection, antibody antigen detection and proteinase K products. In 2021, the company acquired Yurogen. The company manufactures laboratory supplies and provides CRO services, serving global scientific research institutions, drug research and development institutions, and diagnostic industry businesses. The company generates revenue through the sale of antibody products. Clients can place their orders through the company’s website. Going forward, ABclonal, Inc. will look to expand its biology reagent products.
Who invested in ABclonal
24 investors across 7 rounds
See all investors in ABclonal
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Dec 8, 2021
Amount
$188M
Investors
Series C
Feb 22, 2021
Amount
$93M
Investors
Series C
Dec 18, 2020
Amount
$92M
Investors
Series B
Aug 15, 2019
Amount
Undisclosed
Investors
Series A
Jan 15, 2019
Amount
Undisclosed
Investors
Series A
Mar 9, 2018
Amount
Undisclosed
Investors
Angel
Jun 14, 2016
Amount
Undisclosed
Investors
Questions about ABclonal
Who invested in ABclonal?
ABclonal has 24 investors on record across 7 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ABclonal raised?
ABclonal has raised 7 venture rounds. Sign up free to see how much each round raised and the total.
When did ABclonal last raise money?
ABclonal's most recent round on record is a Series D, in Dec 2021.
What does ABclonal do?
Based in Wuhan, China, ABclonal, Inc.
Where is ABclonal headquartered?
ABclonal is headquartered in Wuhan, China.
Which VCs invest in companies like ABclonal?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at ABclonal's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like ABclonal? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.